cholestyramine


Also found in: Thesaurus, Medical, Encyclopedia, Wikipedia.

cho·le·styr·a·mine

 (kō′lĭ-stîr′ə-mēn′, kō-lĕs′tə-răm′ēn)
n.
A drug that binds to intestinal bile acids and promotes their excretion, used to lower serum cholesterol levels and to treat itching associated with partial biliary obstruction.

cholestyramine

(ˌkɒlɪˈstaɪərəˌmiːn)
n
(Pharmacology) a drug that reduces and prevents re-absorption of bile in the body
Translations

cholestyramine

n colestiramina
References in periodicals archive ?
MEVACOR was compared to cholestyramine in a randomized open parallel study.
Multiple relapses on Clostridium difficile-associated diarrhea in a cancer patient: successful control with long-term cholestyramine therapy.
Specific therapies [34], including chloroquine, [beta]-carotene, charcoal, and cholestyramine, did not interfere.
Now I'm seeing that even with my heterozygous familial hypercholesterolemia patients, I can add cholestyramine or niacin to this regimen and do a pretty good job--not everybody gets to target, but it's pretty impressive how many do compared to what we're used to.
Cholestyramine, colestipol, and estrogens may decrease the effectiveness of thyroid hormones.
A variety of foods and drugs can interfere with absorption, including cholestyramine, ferrous sulfate, sucralfate, antacide containing aluminum hydroxide, foods high in fiber, soybean products, and vitamins containing large amounts of iron.
Cholestyramine: In a study of forty healthy hypercholesterolemic (LDL-C (greater than=)130 mg/dL) adult subjects, concomitant cholestyramine (4 g twice daily) administration decreased the mean AUC of total ezetimibe and ezetimibe approximately 55% and 80%, respectively.
Cholestyramine directly binds the anticoagulant and decreases its absorption when the two drugs are taken together.
MacPhee were also elected corporate officers by Par's board of directors; * Par entered into an agreement with MN Pharmaceuticals, based in Istanbul, Turkey, to develop and market generic versions of as many as 10 injectable pharmaceuticals; * Par began shipping leflunomide tablets, cholestyramine regular and light powder for oral suspension, and clonazepam orally disintegrating tablets (ODT); * Par announced that its licensing partner, Amide Pharmaceutical, Inc.
The following drugs may decrease the effectiveness of the sulfonylureas, resulting in hyperglycemia: beta blockers, calcium channel blockers, cholestyramine, corticosteroids, diazoxide, estrogens, hydantoins, isoniazid, nicotinic acid, oral contraceptives, phenothiazines, rifampin, sympathomimetics, thiazide diuretics, thyroid medications, and urinary alkalinizers.